Yohimbe Bark Extract is a botanical ingredient derived from the bark of Pausinystalia johimbe (K. Schum.) Pierre ex Beille, a tree native to tropical regions of western and central Africa. The plant belongs to the Rubiaceae family. Yohimbe bark contains several naturally occurring indole alkaloids, including yohimbine, which is an important analytical marker in certain standardized extracts.
Commercial Yohimbe materials may be supplied as bark powder, conventional bark extract or an extract standardized to a declared yohimbine concentration. These forms differ in composition, processing requirements and intended use. A botanical name or extraction ratio alone does not establish the alkaloid content or quality of the final material.
The accepted botanical identity should be documented as Pausinystalia johimbe (K. Schum.) Pierre ex Beille. The plant family is Rubiaceae, and the bark is the plant part associated with commercial Yohimbe extracts. The spelling of the botanical name should be checked carefully when preparing product labels, specifications and website metadata.
Botanical authentication is important because research on commercial Yohimbe products has identified inconsistent material quality, impurities and possible adulteration in some samples. Appropriate identification procedures and traceable sourcing should therefore form part of the raw-material approval process.
Yohimbe Bark Extract may be produced using a suitable extraction and concentration process. The actual solvent, processing sequence and purification method must be documented for the supplied grade. The extraction ratio should be included only when supported by the manufacturing specification.
Yohimbine is commonly measured as a marker in standardized Yohimbe materials. Depending on the product, the specification may state a percentage of yohimbine by a defined analytical method. High-performance liquid chromatography (HPLC) or another validated chromatographic method may be used, depending on the approved analytical procedure.
The yohimbine content of natural bark and commercial extracts can vary considerably. A claim such as 2%, 6% or another concentration must be supported by the actual grade specification and batch-specific Certificate of Analysis (COA). An extraction ratio does not guarantee a particular yohimbine concentration, and results obtained by different methods should not be assumed to be directly comparable.
Yohimbe Bark Extract powder is commonly described in commercial specifications as a brown to dark-brown material with a characteristic botanical odour. The exact colour, texture and particle-size distribution depend on the bark source, extraction process and drying conditions.
Relevant physical tests may include appearance, odour, moisture content, ash content, particle size and bulk density. Solubility should be described for the actual material and test conditions. These values should be recorded from the approved product specification rather than assumed from a generic botanical description.
Yohimbe Extract requires careful identity and alkaloid testing. The quality specification should identify the botanical source and establish the declared yohimbine content using a validated analytical method. Where relevant, a broader chromatographic fingerprint may help characterize the alkaloid profile rather than relying on a single marker alone.
The quality-control plan should also consider heavy metals, pesticide residues, microbial limits, foreign matter and residual solvents where applicable. Test methods, sample preparation, acceptance limits and reporting units should be documented. Residual-solvent limits must reflect the actual manufacturing process and applicable regulations.
Because the composition of commercial Yohimbe products can be inconsistent, a batch-specific COA is essential. The Technical Data Sheet (TDS) should describe the approved specification, analytical methods, storage conditions and intended material grade. Special claims such as organic certification or other quality certifications should be used only where current documentation supports them.
Yohimbe bark and yohimbine-containing preparations have documented safety concerns. Reported adverse effects associated with yohimbine include changes in blood pressure, rapid heartbeat, cardiac arrhythmias, anxiety and seizures. The European Food Safety Authority concluded that the available chemical and toxicological characterization was insufficient to establish the safety of Yohimbe bark preparations for use in food supplements.
For this reason, a commercial product page should not imply that Yohimbe Extract is universally suitable for foods, supplements or wellness products. Buyers and manufacturers must assess the intended application, target market, ingredient status, labelling requirements and applicable legal restrictions before use. Any health-related or performance claims require separate substantiation and regulatory review.
The intended application of Yohimbe Bark Extract must be determined from the specific grade's technical documentation and the regulations governing the target market. A conventional bark extract and a standardized yohimbine-rich extract should not be treated as interchangeable ingredients.
Before approving a grade, the purchaser should confirm botanical identity, plant part, extraction method, yohimbine assay, other relevant alkaloid information, contaminant testing and residual-solvent results. The documentation should match the actual batch and intended use. No particular use, dosage or health outcome should be inferred solely from the presence of yohimbine.
Store the material in suitable, tightly closed packaging under the conditions stated in the approved TDS. Protect it from moisture, excessive heat, direct sunlight and contamination. Maintain appropriate batch identification, traceability and access controls during storage and handling.
The manufacturer should establish the retest period and shelf life from appropriate supporting documentation. Personnel should follow the approved safety data documentation and workplace handling procedures. Packaging, labelling and transport should comply with the applicable requirements for the intended market.
When evaluating Yohimbe Bark Extract, confirm the botanical name, bark source, extraction method and declared yohimbine concentration. Request a batch-specific COA and a current TDS with the analytical method, acceptance criteria and relevant contaminant results. Do not rely solely on an extraction ratio or a marketing description to establish the identity or strength of the material.
The purchaser should also complete a regulatory review before approving the ingredient for a particular product category. A technically characterized extract is not automatically approved for every intended use or market.
It is a botanical extract prepared from the bark of Pausinystalia johimbe, a tree native to tropical Africa.
Yohimbe belongs to the Rubiaceae family.
Yohimbine is a naturally occurring indole alkaloid found in Yohimbe bark and is used as a marker in certain standardized extracts.
No. Alkaloid content varies by source, processing method and grade. The declared concentration must be verified through the approved specification and batch-specific assay.
Request a current TDS and batch-specific COA, including botanical identification, yohimbine assay, relevant contaminant testing and residual-solvent results where applicable.
No universal suitability should be assumed. Ingredient status, safety and legal requirements must be reviewed for the intended product category and target market.
Follow the approved TDS and safety documentation. Keep the material properly sealed, protected from moisture and contamination, and traceable by batch.
All Yohimbe Bark Extract specifications must reflect the actual grade and batch documentation. Do not publish an assumed yohimbine percentage, extraction ratio, certification or intended-use claim without supporting evidence. Complete the relevant safety and regulatory review before commercial publication or marketing.
| Parameter | Specification |
|---|---|
| Appearance | powder |